Paper ยท 29975751
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.
McNeill RS and 11 others. PLoS One, 2018. Cited by 21 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition. Papers, record 29975751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29975751
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Class I Phosphatidylinositol 3-Kinases | Major topic |
| Glioblastoma | Major topic |
| Mutation, Missense | Major topic |
| Astrocytes | |
| Carcinogenesis | |
| Cell Movement | |
| Cell Proliferation | |
| Cell Transformation, Neoplastic | |
| Drug Synergism | |
| Enzyme Activation | |
| Humans | |
| Mitogen-Activated Protein Kinases | |
| Protein Kinase Inhibitors |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 NS007431 | NINDS NIH HHS | United States | T32NS007431 | PubMed and NIH | NIH RePORTER |
| P30 ES010126 | NIEHS NIH HHS | United States | P30ES010126 | PubMed and NIH | NIH RePORTER |
| R01 CA204136 | NCI NIH HHS | United States | R01CA204136 | PubMed and NIH | NIH RePORTER |
| UL1 TR001111 | NCATS NIH HHS | United States | UL1TR001111 | PubMed and NIH | NIH RePORTER |
| P30 CA016086 | NCI NIH HHS | United States | P30CA016086 | PubMed and NIH | NIH RePORTER |
| T32 GM122741 | NIGMS NIH HHS | United States | T32GM122741 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,397,855 | Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21397855 | PubMed |
| 2 | 20,379,207 | The emerging mechanisms of isoform-specific PI3K signalling. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20379207 | PubMed |
| 3 | 26,826,202 | Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. | Neuro Oncol | 2016 | https://conductscience.org/library/papers/26826202 | PubMed |
| 4 | 27,157,931 | The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/27157931 | PubMed |
| 5 | 22,500,798 | Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer. | Cell | 2012 | https://conductscience.org/library/papers/22500798 | PubMed |
| 6 | 25,146,643 | Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice. | J Vis Exp | 2014 | https://conductscience.org/library/papers/25146643 | PubMed |
| 7 | 24,076,665 | Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. | Nat Med | 2013 | https://conductscience.org/library/papers/24076665 | PubMed |
| 8 | 24,481,312 | PI3K and cancer: lessons, challenges and opportunities. | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/24481312 | PubMed |
| 9 | 11,559,533 | Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. | Cancer Res | 2001 | https://conductscience.org/library/papers/11559533 | PubMed |
| 10 | 23,940,356 | Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23940356 | PubMed |
1 to 10 of 55
See all 55 referencesCited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,278,221 | Potential Association of BRAF and PIK3CA Copy Number Alterations with Long-Term Survival in IDH-Wildtype Glioblastoma: A Pilot Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278221 | PubMed |
| 40,581,663 | Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40581663 | PubMed |
| 40,508,087 | PIK3CA Mutations: Are They a Relevant Target in Adult Diffuse Gliomas? | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508087 | PubMed |
| 39,906,820 | Discovery of mutated oncodriver genes associated with glioblastoma originated from stem cells of subventricular zone through whole exome sequence profile analysis, and drug repurposing. | Heliyon | 2025 | https://conductscience.org/library/papers/39906820 | PubMed |
| 38,778,164 | Arginines of the CGN codon family are Achilles' heels of cancer genes. | Sci Rep | 2024 | https://conductscience.org/library/papers/38778164 | PubMed |
| 38,674,026 | Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38674026 | PubMed |
| 36,844,882 | Recent advances in label-free optical, electrochemical, and electronic biosensors for glioma biomarkers. | Biomicrofluidics | 2023 | https://conductscience.org/library/papers/36844882 | PubMed |
| 36,065,261 | The In Vitro Effect of Psoralen on Glioma Based on Network Pharmacology and Potential Target Research. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/36065261 | PubMed |
| 34,771,425 | Potential Diagnostic Value of the Differential Expression of Histone H3 Variants between Low- and High-Grade Gliomas. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771425 | PubMed |
| 34,423,267 | Fishing for Contact: Modeling Perivascular Glioma Invasion in the Zebrafish Brain. | ACS Pharmacol Transl Sci | 2021 | https://conductscience.org/library/papers/34423267 | PubMed |
1 to 10 of 19
See all 19 cited byGenes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| PIK3CA | 5,290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| PIK3CG | 5,294 | PubTator's text mining | https://conductscience.org/library/genes/5294 | NCBI Gene |
| PIK3R1 | 5,295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| PTEN | 5,728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| RET | 5,979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29975751
GET https://conductscience.org/api/papers/v1/29975751/references?page=2